Loading
Loading…
New
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Amount | Status |
|---|---|---|---|
| 1 | ₹17.2 LAdmitted-Finance | Admitted-Finance |
| Sl No | Description | Qty | Unit | Novartis health Care Private Limited |
|---|---|---|---|---|
| 1.00 | RUXOLITINIB 20MG TABLET | 390 | TAB | 12,05,482.2 ₹13,50,140.06 Lowest |
| 2.00 | RIBOCICLIB 200MG TAB | 420 | NOS | 3,28,692 ₹3,68,135.04 Lowest |
Tender Value
Refer Docs
Closing Date
9 Aug 2025, 11:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
indu vasavi A
indu vasavi A BHEL HYDERABAD
MED_CMM_25_26_005 1. RUXOLITINIB 20MG TABLET 2. RIBOCICLIB 200MG TAB
2025_BHEL_51516_1
MED_CMM_25_26_005 1. RUXOLITINIB 20MG TABLET 2. RIBOCICLIB 200MG TAB
Single
Miscellaneous Goods
Buy
300 days
BHEL HYDERABAD
TECHNICAL SPEC OF THE ENQUIRED PRODUCT WITH YOUR BRAND NAME 2) TYPE OF PACKING
WITH NUMBERS/QTY/BOTTLES 3) AUTHORIZED DEALER LETTER ON YOUR LETTERHEAD 4) VENDOR
ENDORSED SPECIAL TERMS AND CONDITIONS
5 documents required · 5 mandatory
₹0
Exempted
14 Aug 2025
6 Aug 2025
11 Aug 2025
6 Aug 2025
9 Aug 2025
6 Aug 2025
stage.html
html • 0.02 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .